Commerzbank Aktiengesellschaft FI Has $1.79 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Commerzbank Aktiengesellschaft FI raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 53.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,136 shares of the company’s stock after purchasing an additional 5,260 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Cardinal Health were worth $1,785,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Frazier Financial Advisors LLC boosted its stake in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after buying an additional 104 shares in the last quarter. Hara Capital LLC bought a new position in shares of Cardinal Health in the third quarter worth about $31,000. AM Squared Ltd acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $33,000. Kentucky Trust Co acquired a new position in Cardinal Health during the 4th quarter worth approximately $41,000. Finally, HHM Wealth Advisors LLC lifted its stake in Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after purchasing an additional 144 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on CAH shares. Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Argus set a $148.00 target price on Cardinal Health in a report on Tuesday, February 4th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Finally, Morgan Stanley boosted their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Stock Performance

NYSE:CAH opened at $128.96 on Tuesday. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84. The firm’s fifty day moving average is $124.96 and its 200-day moving average is $118.40. The firm has a market cap of $31.15 billion, a P/E ratio of 24.06, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.57%. Cardinal Health’s payout ratio is currently 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.